Jul 15, 2016 - Liraglutide, combined with lifestyle counseling, produces a clinically significant and sustained weight loss that continues as long as it is used. Nausea and vomiting, however, are common adverse effects, and about one in 10 patients will discontinue treatment.
American Family Physician : STEPS
Jul 1, 2012 - Overall, children up to 12 years of age benefited from school-based obesity prevention interventions; this effect was not demonstrated among adolescents 13 years and older. Although the overall effect size was small, interventions that promoted physical activity, alone or in combination...
American Family Physician : Cochrane for Clinicians
Jul 1, 2008 - Childhood obesity is an increasingly serious problem; 13.9 percent of children two to five years of age, 18.8 percent of children six to 11 years of age, and 17.4 percent of adolescents 12 to 19 years of age in America are obese. Practical strategies that primary care physicians can use...
American Family Physician : Article
Nov 1, 2007 - No studies have addressed the question of whether metformin reduces development of diabetes among adolescents who are obese. Metformin treatment in adolescents who are obese can modestly reduce risk factors for type 2 diabetes, including elevated body mass index (BMI), fasting insulin ...
American Family Physician : FPIN's Clinical Inquiries
Oct 15, 2006 - The American Academy of Pediatrics (AAP) policy statement, Active Healthy Living: Prevention of Childhood Obesity Through Increased Physical Activity, addresses how physicians can encourage physical activity in children and adolescents who are currently or are at risk of becoming ...
American Family Physician : Practice Guidelines